Related Experiment Video
Updated: Jun 30, 2026
05:31
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Bio-Valsalva prosthesis: 'new' conduit for 'old' patients
Roberto Di Bartolomeo1, Luca Botta, Alessandro Leone
1Department of Cardiac Surgery, University of Bologna, Policlinico S Orsola-Malpighi, Bologna, Italy.
Interactive Cardiovascular and Thoracic Surgery
|September 20, 2008
Summary
The new Bio-Valsalva conduit offers a viable option for aortic root replacement in elderly patients. Early results show ease of use and good hemostatic properties, with no structural deterioration observed.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
- Prosthetic Devices
Background:
- Aortic root replacement is a complex procedure, particularly in elderly patients.
- Existing prosthetic options may have limitations for specific patient populations.
- The Bio-Valsalva conduit presents a novel integrated solution for aortic root reconstruction.
Purpose of the Study:
- To evaluate the early clinical outcomes of the Bio-Valsalva conduit in patients undergoing composite aortic root replacement.
- To assess the safety, efficacy, and implantability of this new bio-prosthetic valved conduit.
Main Methods:
- Retrospective analysis of 21 patients who underwent aortic root replacement using the Bio-Valsalva prosthesis.
- Procedures included composite root replacement, hemi-arch, and total arch replacement.
- Data collected on in-hospital outcomes, complications, and early follow-up.
Main Results:
- One in-hospital mortality (4.7%) and one re-thoracotomy for bleeding.
- Median in-hospital stay was 12 days.
- No re-operations or structural deterioration were noted during the median six-month follow-up.
Conclusions:
- The Bio-Valsalva graft demonstrates ease of implantation and favorable hemostatic characteristics in early use.
- Further investigation with larger patient cohorts and longer follow-up is warranted to confirm its long-term benefits.
Related Concept Videos
01:27Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
01:28Tracheostomy: Procedure and Tubes
A tracheostomy is a surgical procedure that creates an artificial opening into the trachea, typically at the second or third cartilaginous ring level. This opening allows the insertion of a tracheostomy tube, which can replace an endotracheal tube, provide mechanical ventilation, bypass an upper airway obstruction, or remove accumulated tracheobronchial secretions.
Tracheostomy tubes can be made of semiflexible plastic (polyurethane or silicone), rigid plastic, or metal, and they come in...
Tracheostomy tubes can be made of semiflexible plastic (polyurethane or silicone), rigid plastic, or metal, and they come in...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.